CARGO THERAPEUTICS INC (CRGX) Stock Overview
USA - NASDAQ:CRGX - US14179K1016 - Common Stock
CRGX Key Statistics, Chart & Performance
The current stock price of CRGX is 4.47 USD. In the past month the price decreased by -1.11%. In the past year, price decreased by -75.1%.
CRGX Latest News, Press Relases and Analysis
CRGX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.53 | 402.76B | ||
| AMGN | AMGEN INC | 13.38 | 157.07B | ||
| GILD | GILEAD SCIENCES INC | 15.63 | 150.06B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.88 | 108.04B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.66 | 61.26B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.75B | ||
| ARGX | ARGENX SE - ADR | 88.74 | 50.32B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.02 | 34.14B | ||
| INSM | INSMED INC | N/A | 33.75B | ||
| NTRA | NATERA INC | N/A | 26.42B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.40B | ||
| BIIB | BIOGEN INC | 9.36 | 21.98B |
Related stock screener links
About CRGX
Company Profile
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 167 full-time employees. The firm's programs, platforms, and manufacturing strategy were designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is an engineered protein that is delivered into T cells, enabling recognition and destruction of cancer cells.
Company Info
CARGO THERAPEUTICS INC
835 Industrial Road, Suite 400
San Carlos CALIFORNIA US
Employees: 167
Phone: 16504998950
CARGO THERAPEUTICS INC / CRGX FAQ
What does CARGO THERAPEUTICS INC do?
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 167 full-time employees. The firm's programs, platforms, and manufacturing strategy were designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is an engineered protein that is delivered into T cells, enabling recognition and destruction of cancer cells.
Can you provide the latest stock price for CARGO THERAPEUTICS INC?
The current stock price of CRGX is 4.47 USD. The price decreased by -1.54% in the last trading session.
What is the dividend status of CARGO THERAPEUTICS INC?
CRGX does not pay a dividend.
What is the ChartMill rating of CARGO THERAPEUTICS INC stock?
CRGX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of CRGX stock?
CARGO THERAPEUTICS INC (CRGX) operates in the Health Care sector and the Biotechnology industry.
Should I buy CRGX stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CRGX.
What is CARGO THERAPEUTICS INC worth?
CARGO THERAPEUTICS INC (CRGX) has a market capitalization of 216.17M USD. This makes CRGX a Micro Cap stock.
CRGX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CRGX. When comparing the yearly performance of all stocks, CRGX is a bad performer in the overall market: 93.99% of all stocks are doing better.
CRGX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CRGX. While CRGX has a great health rating, there are worries on its profitability.
CRGX Financial Highlights
Over the last trailing twelve months CRGX reported a non-GAAP Earnings per Share(EPS) of -3.66. The EPS increased by 92.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -85.76% | ||
| ROE | -93.3% | ||
| Debt/Equity | 0 |
CRGX Forecast & Estimates
11 analysts have analysed CRGX and the average price target is 5.61 USD. This implies a price increase of 25.5% is expected in the next year compared to the current price of 4.47.